Multiple sclerosis: Validation of MR imaging for quantification and detection of iron

Radiology

Volumn 267, Issue 2, 2013, Pages 531-542

  Walsh, Andrew J ^a   Lebel, R Marc ^a   Eissa, Amir ^a   Blevins, Gregg ^a   Catz, Ingrid ^a   Lu, Jian Qiang ^a   Resch, Lothar ^a   Johnson, Edward S ^a   Emery, Derek J ^a   Warren, Kenneth G ^a   Wilman, Alan H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; ARTICLE; BRAIN MAPPING; CASE REPORT; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GRAY MATTER; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE DISPLAY; IN VIVO STUDY; IRON STAINING; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; STAINING; VALIDATION PROCESS;

BRAIN; CADAVER; CAUSE OF DEATH; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; LEAST-SQUARES ANALYSIS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 84876896854     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12120863     Document Type: Article

References (48)

1. Williams R, Buchheit CL, Berman NE, LeVine SM. Pathogenic implications of iron accumulation in multiple sclerosis. J Neurochem 2012;120(1):7-25.
2. Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I. Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982;106(8):397-399.
3. LeVine SM. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 1997;760(1-2):298-303.
4. Adams CW. Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry 1988; 51(2):260-265.
5. Drayer B, Burger P, Hurwitz B, Dawson D, Cain J. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am J Roentgenol 1987;149(2):357-363.
6. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23(1):1-25.
7. Schenck JF, Zimmerman EA. High-field magnetic resonance imaging of brain iron: birth of a biomarkeř NMR Biomed 2004; 17(7):433-445.
8. Ogg RJ, Langston JW, Haacke EM, Steen RG, Taylor JS. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging 1999;17(8):1141-1148.
9. Shmueli K, de Zwart JA, van Gelderen P, Li TQ, Dodd SJ, Duyn JH. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn Reson Med 2009;62(6):1510-1522.
10. Zhang Y, Zabad RK, Wei X, Metz LM, Hill MD, Mitchell Jr. Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult Scler 2007;13(7):880-883.
11. Khalil M, Langkammer C, Ropele S, et al. Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 2011;77(18):1691- 1697.
12. Lebel RM, Eissa A, Seres P, Blevins G, Wilman AH. Quantitative high-field imaging of sub-cortical gray matter in multiple sclerosis. Mult Scler 2012;18(4):433-441.
13. Ge Y, Jensen JH, Lu H, et al. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007;28(9):1639-1644.
14. Mitsumori F, Watanabe H, Takaya N. Estimation of brain iron concentration in vivo using a linear relationship between regional iron and apparent transverse relaxation rate of the tissue water at 4.7T. Magn Reson Med 2009;62(5):1326-1330.
15. He X, Yablonskiy DA. Biophysical mechanisms of phase contrast in gradient echo MRI. Proc Natl Acad Sci U S A 2009; 106(32):13558-13563.
16. Wharton S, Bowtell R. Whole-brain susceptibility mapping at high field: a comparison of multiple-and single-orientation methods. Neuroimage 2010;53(2):515-525.
17. Yao B, Li TQ, Gelderen P, Shmueli K, de Zwart JA, Duyn JH. Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage 2009;44(4):1259-1266.
18. Wallis LI, Paley MN, Graham JM, et al. MRI assessment of basal ganglia iron deposition in Parkinson's disease. J Magn Reson Imaging 2008;28(5):1061-1067.
19. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3(1):41-51.
20. Hopp K, Popescu BF, McCrea RP, et al. Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X-ray fluorescence. J Magn Reson Imaging 2010; 31(6):1346-1354.
21. Langkammer C, Krebs N, Goessler W, et al. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 2010; 257(2):455-462.
22. Bagnato F, Hametner S, Yao B, et al. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 2011;134(Pt 12):3602-3615.
23. Schrag M, McAuley G, Pomakian J, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol (Berl) 2010;119(3):291-302.
24. Yao B, Bagnato F, Matsuura E, et al. Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging. Radiology 2012;262(1):206-215.
25. Dawe RJ, Bennett DA, Schneider JA, Vasireddi SK, Arfanakis K. Postmortem MRI of human brain hemispheres: T2 relaxation times during formaldehyde fixation. Magn Reson Med 2009;61(4):810-818.
26. van Duijn S, Nabuurs RJ, van Rooden S, et al. MRI artifacts in human brain tissue after prolonged formalin storage. Magn Reson Med 2011;65(6):1750-1758.
27. Bischoff K, Lamm C, Erb HN, Hillebrandt Jr. The effects of formalin fixation and tissue embedding of bovine liver on copper, iron, and zinc analysis. J Vet Diagn Invest 2008;20(2):220-224.
28. Shepherd TM, Flint JJ, Thelwall PE, et al. Postmortem interval alters the water relaxation and diffusion properties of rat nervous tissue: implications for MRI studies of human autopsy samples. Neuroimage 2009;44(3):820-826.
29. Schrag M, Dickson A, Jiffry A, Kirsch D, Vinters HV, Kirsch W. The effect of formalin fixation on the levels of brain transition metals in archived samples. Biometals 2010;23(6):1123-1127.
30. Lebel RM, Wilman AH. Time-efficient fast spin echo imaging at 4.7 T with low refocusing angles. Magn Reson Med 2009;62(1): 96-105.
31. Lebel RM, Wilman AH. Transverse relaxometry with stimulated echo compensation. Magn Reson Med 2010;64(4):1005-1014.
32. Meguro R, Asano Y, Odagiri S, Li CT, Iwatsuki H, Shoumura K. Nonheme-iron histochemistry for light and electron microscopy: a historical, theoretical and technical review. Arch Histol Cytol 2007;70(1): 1-19.
33. Rasband WS. ImageJ. US National Institutes of Health, Bethesda, Maryland, 1997-2011.
34. Bizzi A, Brooks RA, Brunetti A, et al. Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths. Radiology 1990;177(1):59-65.
35. Vaughan JT, Garwood M, Collins CM, et al. 7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images. Magn Reson Med 2001;46(1):24-30.
36. Baudrexel S, Volz S, Preibisch C, et al. Rapid single-scan T2-mapping using exponential excitation pulses and imagebased correction for linear background gradients. Magn Reson Med 2009;62(1): 263-268.
37. Du YPP, Jin ZY, Hu YZ, Tanabe J. Multiecho acquisition of MR angiography and venography of the brain at 3 Tesla. J Magn Reson Imaging 2009;30(2):449-454.
38. Haacke EM, Xu Y, Cheng YC, Reichenbach Jr. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52(3):612-618.
39. Schäfer A, Wharton S, Gowland P, Bowtell R. Using magnetic field simulation to study susceptibility-related phase contrast in gradient echo MRI. Neuroimage 2009;48(1): 126-137.
40. Walsh AJ, Eissa A, Blevins G, Wilman AH. Susceptibility phase imaging with improved image contrast using moving window phase gradient fitting and minimal filtering. J Magn Reson Imaging doi:10.1002/jmri.23768. Published online August 3, 2012.
41. Masuda T, Kasai T, Satodate R. Quantitative measurement of hemosiderin deposition in tissue sections of the liver by image analysis. Anal Quant Cytol Histol 1993;15(6):379-382.
42. Hammond KE, Metcalf M, Carvajal L, et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 2008; 64(6):707-713.
43. Pawate S, Wang L, Song Y, Sriram S. Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies. J Neuroimaging 2012; 22(2):137-144.
44. Haacke EM, Makki M, Ge YL, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 2009;29(3):537-544.
45. Hagemeier J, Heininen-Brown M, Poloni GU, et al. Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study. J Magn Reson Imaging 2012;36(1):73-83.
46. Schweser F, Deistung A, Lehr BW, Reichenbach Jr. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage 2011; 54(4):2789-2807.
47. Liu T, Khalidov I, de Rochefort L, et al. A novel background field removal method for MRI using projection onto dipole fields (PDF). NMR Biomed 2011;24(9): 1129-1136.
48. Laule C, Kozlowski P, Leung E, Li DK, Mackay AL, Moore GR. Myelin water imaging of multiple sclerosis at 7 T: correlations with histopathology. Neuroimage 2008;40(4): 1575-1580.